Prevalence of Psoriasis and Rosacea Comorbidities in the Outpatient Setting

Kimball AB Gladman D Gelfand JM . National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 2008;58:1031–42, doi:10.1016/j.jaad.2008.01.006.

Crawford GH Pelle MT James WD . Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004;51:327–41, doi:10.1016/j.jaad.2004.03.030.

National Psoriasis Foundation. Statistics. Available at http://www.psoriasis.org/researchers/science-of-psoriasis/statistics (accessed September 2011).

Yentzer BA Fleischer AB Jr . Changes in rosacea comorbidities and treatment utilization over time. J Drugs Dermatol 2010;9:1402–6.

Gupta MA Gupta AK Chen SJ Johnson AM . Comorbidity of rosacea and depression: An analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey—outpatient department data collected by the U.S. National Center for Health Statistics from 1995 to 2002. Br J Dermatol 2005;153:1176–81, doi:10.1111/j.l365-2133.2005.06895.x.